NCT03203694

Brief Summary

The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Dec 2017

Longer than P75 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

December 4, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2022

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

April 4, 2024

Completed
Last Updated

April 4, 2024

Status Verified

April 1, 2024

Enrollment Period

4.3 years

First QC Date

June 23, 2017

Results QC Date

September 28, 2023

Last Update Submit

April 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Insulin-stimulated Leg Blood Flow Calculated as Percent Change (t0, t60)

    Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed at baseline (t0) and after 60 minutes of insulin stimulation (t60).

    Percent change from baseline leg blood flow during 60 minutes of insulin stimulation.

  • Net Change in Insulin-stimulated Leg Blood Flow Calculated as Percent Change From Pre-intervention (t0,t60) to Post-intervention (t0,t60).

    Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed pre-intervention and post-intervention at baseline (t0) and after 60 minutes of insulin stimulation (t60). Outcome measure indicates whether percent change in insulin-stimulated blood flow increased or decreased following intervention. Interventions that show an increase demonstrate an improvement in insulin-stimulated blood flow.

    Change from baseline insulin-stimulated leg blood flow following 1 heating session, 7 days of heating intervention, or 8 weeks of walking intervention/no intervention.

Study Arms (6)

Walking: Intervention arm in diabetics

EXPERIMENTAL

The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.

Behavioral: Walking: Intervention arm in diabetics

Walking: No intervention in diabetics

EXPERIMENTAL

Subjects will be instructed to continue their usual lifestyle for 8 weeks.

Other: Walking: No intervention in diabetics

Walking: Healthy cohort as reference controls

OTHER

Subjects will be studied at one time only.

Other: Walking: Healthy cohort as reference controls

Lower body heating: Intervention arm in healthy subjects

EXPERIMENTAL

This intervention consists of 60 minutes of lower body heating (40-42 degree C).

Behavioral: Lower body heating: Intervention arm in healthy subjects

Lower body heating: Intervention arm in diabetics

EXPERIMENTAL

This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.

Behavioral: Lower body heating: Intervention arm in diabetics

Lower body heating: Healthy cohort as reference controls

OTHER

Subjects will be studied at one time only.

Other: Lower body heating: Healthy cohort as reference controls

Interventions

The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.

Walking: Intervention arm in diabetics

Subjects will be instructed to continue their usual lifestyle for 8 weeks.

Walking: No intervention in diabetics

Subjects will be studied at one time only.

Walking: Healthy cohort as reference controls

This intervention consists of 60 minutes of lower body heating (40-42 degree C).

Lower body heating: Intervention arm in healthy subjects

This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.

Lower body heating: Intervention arm in diabetics

Subjects will be studied at one time only.

Lower body heating: Healthy cohort as reference controls

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with type 2 diabetes who are overweight and obese (BMI 25-50 kg/m2), 35 to 65 years of age, and sedentary (\<60 minutes structured exercise/week). Healthy volunteers without type 2 diabetes: 18 to 65 years of age.

You may not qualify if:

  • Cardiovascular disease including myocardial infraction, heart failure, coronary artery disease, stroke;
  • renal or hepatic diseases;
  • active cancer;
  • autoimmune diseases;
  • immunosuppressant therapy;
  • excessive alcohol consumption (\>14 drinks/week for men; \>7 drinks/week for women);
  • current tobacco use;
  • pregnancy;
  • mobility limitations;
  • foot ulcers;
  • diabetic neuropathy
  • uncontrolled hypertension (\>=180 systolic / 100 diastolic mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Jaume Padilla
Organization
University of Missouri

Study Officials

  • Jaume Padilla, PhD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be assigned to either a walking, a lower body heating, or no intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 23, 2017

First Posted

June 29, 2017

Study Start

December 4, 2017

Primary Completion

March 10, 2022

Study Completion

March 10, 2022

Last Updated

April 4, 2024

Results First Posted

April 4, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations